ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

about

Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells.

P2860

Q54939991-77125944-F8F6-4F12-B386-042D5144FC6D

P2860

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

Item

http://www.wikidata.org/entity/Q41548025

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

@en

type

Item

label

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

@en

prefLabel

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

@en

P1476

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

@en

P2093

Daoping Zhou

http://www.w3.org/2001/XMLSchema#string

Juan Gu

http://www.w3.org/2001/XMLSchema#string

Soldano Ferrone

http://www.w3.org/2001/XMLSchema#string

Xinhui Wang

http://www.w3.org/2001/XMLSchema#string

Xuedong Wang

http://www.w3.org/2001/XMLSchema#string

Yueping Wang

http://www.w3.org/2001/XMLSchema#string

Zhimin He

http://www.w3.org/2001/XMLSchema#string

P2860

ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis

Knockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2

Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes

Selective modulation of integrin-mediated cell migration by distinct ADAM family members

ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.

P2888

s41598-017-10468-x

P304

9687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-10468-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28852196

http://www.w3.org/2001/XMLSchema#string

P932

5575004

http://www.w3.org/2001/XMLSchema#string

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

about

P2860

P2860

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932